Inspire HGNS denied as duplicate or overlapping therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for inspire hgns are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Inspire HGNS as "Duplicate Therapy" — and How to Appeal

A "duplicate therapy" denial for Inspire Upper Airway Stimulation (hypoglossal nerve stimulation, HGNS) typically occurs when Blue Cross Blue Shield's claims system detects that another treatment for obstructive sleep apnea — most commonly CPAP or a mandibular advancement device — is also active or was recently billed. The insurer's logic is that you are already receiving treatment for the same condition, making the implant duplicative. This characterization is almost always clinically inaccurate: patients who qualify for Inspire HGNS do so precisely because they have already tried and failed other therapies. The denial reason and the clinical reality are in direct conflict.

## Federal Appeal Framework

ERISA §503 requires full-and-fair internal review for most employer-sponsored plans. ACA §2719 adds independent external review rights. You typically have 180 days from the denial to file an internal appeal and approximately four months from the final internal denial to request external review. Expedited review (72-hour decision) is available when delay would seriously jeopardize your health.

## Your Concrete Appeal Steps

1. Identify which prior therapy triggered the "duplicate" flag — review your EOB and request Aetna's written explanation of what claim or active benefit was deemed duplicative. 2. Establish clinical discontinuation or inadequacy of the prior therapy — if CPAP was prescribed but is no longer in use because it was ineffective or intolerable, document that explicitly. An active CPAP equipment rental does not mean active therapeutic use. 3. Obtain your prescriber's letter distinguishing the therapies — your sleep physician should explain that Inspire HGNS is not duplicative but is a replacement therapy indicated specifically because prior treatments failed, with dates and clinical detail. 4. Cite the clinical pathway — BCBS's own coverage policy for Inspire HGNS (available through your BCBS plan's medical policy portal) likely requires prior CPAP failure as a condition of coverage, which is the opposite of duplication. 5. File the internal appeal with the prescriber's letter and prior-therapy records. 6. Request external review if internal appeal is denied.

## Documentation to Gather

• Records of prior CPAP or oral appliance therapy with dates of initiation and discontinuation
• CPAP adherence data or clinical notes documenting intolerance/failure
• Prescriber's letter explicitly stating that Inspire HGNS replaces, rather than duplicates, prior therapy
• Sleep study confirming ongoing, inadequately treated obstructive sleep apnea
• BCBS's own coverage policy for Inspire HGNS (printed from their medical policy site), showing that CPAP failure is a prerequisite

## Criteria-Mapping Structure

In your appeal letter, create a table with columns: BCBS policy requirement | Your chart evidence | Key fact. Pull each coverage criterion verbatim from BCBS's published medical policy. For the duplicate-therapy denial specifically, argue that the policy's own step-therapy requirement (prior CPAP failure) is proof that the therapies are sequential, not simultaneous — and that your records document the completed prior step.